oa Erratum

Due to an oversight on the part of the authors, Robinson MJ, Ahl J, Meyers AL, McCarberg BH, Iyengar S, errors were published in the manuscript entitled “Management of Painful Symptoms with Duloxetine: A Review of the Efficacy in Pre-Clinical and Clinical Studies”, Curr Drug Ther 2011; 6: pp. 121-136. On page 123, an incorrect study length was reported for the DPNP studies. The correct study length is 12 weeks instead of 12-13 weeks. On page 131, an incorrect dose was listed in Table 9 in the column heading under Studies V & VI. The correct dose is 60 mg QD instead of 60 mg BID. Finally, references 54 and 55 were reversed. The correct Reference 54 is Raskin J, Pritchett YL, Wang F, et al. A double-blind, randomized multicenter trial comparing duloxetine with placebo in the management of diabetic peripheral neuropathic pain. Pain Med 2005; 6(5): 346-56. The correct Reference 55 is Wernicke JF, Pritchett YL, D'Souza DN, et al. A randomized controlled trial of duloxetine in diabetic peripheral neuropathic pain. Neurology 2006; 67(8): 1411-20.